Telix Pharma Upsizes Convertible Bond Deal to $600 Million

Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia’s largest such offering this year. The company’s shares fell....

Redirecting to full article...